Loss of glycosaminoglycan (GAG) chains of proteoglycans (PGs) is an early event of osteoarthritis (OA) resulting in cartilage degradation that has been previously demonstrated in both huma and experimental OA models. However, the mechanism of GAG loss and the role of xylosyltransferase-I (XT-I) that initiates GAG biosynthesis onto PG molecules in the pathogenic process of human OA are unknown. In this study, we have characterized XT-I expression and activity together with GAG synthesis in human OA cartilage obtained from different regions of the same joint, defined as “normal”, “late-stage” or adjacent to “late-stage”. The results showed that GAG synthesis and content increased in cartilage from areas flanking OA lesions compared to cartilage from macroscopically “normal” unaffected regions, while decreased in “late-stage” OA cartilage lesions. This increase in anabolic state was associated with a marked upregulation of XT-I expression and activity in cartilage “next to lesion” while a decrease in the “late-stage” OA cartilage. Importantly, XT-I inhibition by shRNA or forced-expression with a pCMV-XT-I construct correlated with the modulation of GAG anabolism in human cartilage explants. The observation that XT-I gene expression was down-regulated by IL-1β and up-regulated by TGF-β1 indicates that these cytokines may play a role in regulating GAG content in human OA. Noteworthy, expression of IL-1β receptor (IL-1R1) was down-regulated whereas that of TGF-β1 was up-regulated in early OA cartilage. Theses observations may account for upregulation of XT-I and sustained GAG synthesis prior to the development of cartilage lesions during the pathogenic process of OA.
References
[1]
Heinegard D, Saxne T (2011) The role of the cartilage matrix in osteoarthritis. Nature Reviews Rheumatology 7: 50–56.
[2]
Mankin HJ, Lippiello L (1970) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg Am 52: 424–434.
[3]
Pratta MA, Yao W, Decicco C, Tortorella MD, Liu RQ, et al. (2003) Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem 278: 45539–45545.
[4]
Kapoor M, Johanne Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. osteoarthritis. Nature Reviews Rheumatology 7: 33–42.
[5]
Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, et al. (2011) Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 21: 202–220.
[6]
Hardingham TE, Bayliss MT, Rayan V, Noble DP (1992) Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Br J Rheumatol 31: Suppl 11–6.
[7]
Roughley PJ (2006) The structure and function of cartilage proteoglycans. Eur Cell Mater 12: 92–101.
[8]
Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67: 609–652.
[9]
Hermansson M, Sawaji Y, Bolton M, Alexander S, Wallace A, et al. (2004) Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 279: 43514–43521.
[10]
Young AA, Smith MM, Smith SM, Cake MA, Ghosh P, et al. (2005) Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther 7: R852–R861.
[11]
Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44: 2777–2789.
[12]
Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, et al. (1998) Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 102: 2115–2125.
[13]
Venkatesan N, Barré L, Magdalou J, Mainard D, Netter P, et al. (2009) Modulation of xylosyltransferase I expression provides a mechanism regulating glycosaminoglycan chain synthesis during cartilage destruction and repair. FASEB J 23: 813–822.
[14]
Altman R, Asch E, Bloch D, Bole G, Borenstein D, et al. (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 29: 1039–1049.
[15]
Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53: 523–537.
[16]
Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J (1996) The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4: 77–84.
[17]
Larsson SE, Kuettner KE (1974) Microchemical studies of acid glycosaminoglycans from isolated chondrocytes in suspension. Calcif Tissue Res 14: 49–58.
[18]
de Vries BJ, van den Berg WB, Vitters E, van de Putte LBA (1986) Quantitation of glycosaminoglycan metabolism in anatomically intact articular cartilage of the mouse patella: in vitro and in vivo studies with 35S-sulfate, 3Hglucosamine, and 3H-acetate. Rheumatol Int 6: 273–281.
[19]
Vincourt JB, Lionneton F, Kratassiouk G, Guillemin F, Netter P, et al. (2006) Establishment of a reliable method for direct proteome characterization of human articular cartilage. Mol Cell Proteomics 5: 1984–1995.
[20]
Weilke C, Brinkmann T, Kleesiek K (1997) Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor. Clin Chem 43: 45–51.
[21]
Calabro A, Hascall VC, Midura RJ (2000) Adaptation of FACE methodology for microanalysis of total hyaluronan and chondroitin sulfate composition from cartilage. Glycobiology 10: 283–293.
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 76: 248–254.
[24]
Mastbergen SC, Jansen NW, Bijlsma JW, Lafeber FP (2006) Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. Arthritis Res Ther 8: R2.
[25]
Yagi R, McBurney D, Laverty D, Weiner S, Horton WE Jr (2005) Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 23: 1128–1138.
[26]
Squires GR, Okouneff S, Ionescu M, Poole AR (2003) The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 48: 1261–1270.
[27]
Aurich M, Mwale F, Reiner A, Mollenhauer JA, Anders JO, et al. (2006) Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface. Arthritis Rheum 54: 244–252.
[28]
Hickery MS, Bayliss MT (1998) Interleukin-1 induced nitric oxide inhibits sulphation of glycosaminoglycan chains in human articular chondrocytes. Biochim Biophys Acta 1425: 282–290.
[29]
Tyler JA (1985) Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J 227: 869–878.
[30]
Hardingham TE, Rayan V, Lewthwaite JC (1994) Regulation of cartilage matrix synthesis by chondrocytes. Rev Rhum Ed Fr 6: 93S–98S.
[31]
Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB (1998) Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-β into murine knee joints. Lab Invest 78: 133–142.
[32]
Blaney Davidson EN, van der Kraan PM, van den Berg WB (2007) TGF-β and osteoarthritis. Osteoarthritis Cartilage 15: 597–604.
[33]
Thompson RC Jr, Oegema TR Jr (1979) Metabolic activity of articular cartilage in osteoarthritis. An in vitro study. J Bone Joint Surg Am 61: 407–416.
[34]
Rizkalla G, Reiner A, Bogoch E, Poole AR (1992) Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 90: 2268–2277.
[35]
van Lent PL, van de Loo FA, Holthuysen AE, van den Bersselaar LA, Vermeer H, et al. (1995) Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J Rheumatol 22: 2250–2258.
[36]
Bird TA, Saklatvala J (1986) Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells. Nature 324: 263–266.
[37]
Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, et al. (1988) cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585–589.
[38]
Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095–2147.
[39]
Pujol JP, Chadjichristos C, Legendre F, Bauge C, Beauchef G, et al. (2008) Interleukin-1 and transforming growth factor-β1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res 49: 293–297.
[40]
Boumediene K, Conrozier T, Mathieu P, Richard M, Marcelli C, et al. (1998) Decrease of cartilage transforming growth factor-beta receptor II expression in the rabbit experimental osteoarthritis-potential role in cartilage breakdown. Osteoarthritis Cartilage 6: 146–149.
[41]
Radons J, Bosserhoff AK, Gr？ssel S, Falk W, Schubert TE (2006) p38MAPK mediates IL-1-induced down-regulation of aggrecan gene expression in human chondrocytes. Int J Mol Med 17: 661–668.
[42]
Kuettner KE, Cole AA (2005) Cartilage degeneration in different human joints. Osteoarthritis Cartilage 13: 93–103.
[43]
Rayan V, Hardingham T (1994) The recovery of articular cartilage in explant culture from interleukin-1 alpha: effects on proteoglycan synthesis and degradation. Matrix Biol 14: 263–271.
[44]
Susarla BT, Laing ED, Yu P, Katagiri Y, Geller HM, Symes AJ (2011) Smad proteins differentially regulate transforming growth factor-β-mediated induction of chondroitin sulfate proteoglycans. J Neurochem 119: 868–878.
[45]
Prante C, Milting H, Kassner A, Farr M, Ambrosius M, et al. (2007) Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J Biol Chem 282: 26441–26449.
